Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
OSUR: Stock Quote & Summary Data
0.72%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 5.00 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 222,358 |
| Previous Close | $ 4.18 |
| 52 Wk High / Low | $ 4.55 / $ 2.16 |
| Shares Outstanding | 45,918,000 |
| Market Value | $ 190,559,700 |
| P/E Ratio | NE |
| Forward P/E (1yr) | NE |
| Earnings Per Share | $ -0.69 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 1.37 |
| NASDAQ Official Open Price: | $ 4.15 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 4.15 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About OSUR?
Ask your question about about OraSure Technologies, Inc. (OSUR) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
Our business principally involves the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using our proprietary oral fluid technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types, and other medical devices. Our diagnostic products include tests which are performed on a rapid basis at the point of care and tests which are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. One of our products has been sold in the over-the-counter (“OTC”) or consumer retail market in the United States, Canada, Europe, Mexico and Australia. ... More ...
Links to all OraSure Technologies, Inc. (OSUR) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for OSUR |
||
|
OraSure Agrees To Pay $3 Mln To Inverness For Settlement Of Patent Lawsuit; Sees Wider Loss In Q4 - Update - RTT News 11/19/2009 1:53PM |
||
|
OraSure Technologies Announces Settlement Of Patent Infringement Lawsuit With Inverness And Church & Dwight - Quick Facts - RTT News 11/19/2009 6:07AM |
||
|
OraSure Technologies Announces Settlement of Patent Infringement Lawsuit With Inverness and Church & Dwight - GlobeNewswire 11/19/2009 6:00AM |
||
|
OraSure Technologies Participates in BPAC Meeting on HIV Over-the-Counter Test - GlobeNewswire 11/18/2009 10:41AM |
||
|
OraSure Announces 2009 Third Quarter Financial Results - GlobeNewswire 11/04/2009 4:00PM |
||
|
OraSure Technologies Earnings Conference Call Invitation - GlobeNewswire 10/22/2009 4:00PM |
||
|
OraSure Tech. Awarded Premier Contract For Its OraQuick ADVANCE Rapid HIV-1/2 Antibody Test - Quick Facts - RTT News 09/24/2009 6:21AM |
